EDGAR Filing Documents for 0001193125-23-012151

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]

SEC Accession No. 0001193125-23-012151

Filing Date

2023-01-20

Accepted

2023-01-20 17:19:43

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	S-1/A	d143161ds1a.htm	S-1/A	1507517
2	EX-1.1	d143161dex11.htm	EX-1.1	218347
3	EX-4.4	d143161dex44.htm	EX-4.4	112062
4	EX-4.6	d143161dex46.htm	EX-4.6	61669
5	EX-5.1	d143161dex51.htm	EX-5.1	18604
6	EX-10.2	d143161dex102.htm	EX-10.2	72786
7	EX-10.3	d143161dex103.htm	EX-10.3	95416
8	EX-10.5	d143161dex105.htm	EX-10.5	19172
9	EX-10.7	d143161dex107.htm	EX-10.7	11311
10	EX-10.8	d143161dex108.htm	EX-10.8	19113
11	EX-10.9	d143161dex109.htm	EX-10.9	36514
12	EX-23.1	d143161dex231.htm	EX-23.1	1404
13	GRAPHIC	g143161g25m25.jpg	GRAPHIC	117689
	Complete submission text file	0001193125-23-012151.txt		2337139

Mailing Address 10900 NE 4TH STREET, SUITE 2300 BELLEVUE WA 98004

Business Address 10900 NE 4TH STREET, SUITE 2300 BELLEVUE WA 98004 425-635-7700

Bellevue Life Sciences Acquisition Corp. (Filer) CIK: 0001840425 (see all company filings)